ATE181326T1 - Verfahren zu diastereoselektiven herstellung von nucleosid analoga - Google Patents

Verfahren zu diastereoselektiven herstellung von nucleosid analoga

Info

Publication number
ATE181326T1
ATE181326T1 AT95918579T AT95918579T ATE181326T1 AT E181326 T1 ATE181326 T1 AT E181326T1 AT 95918579 T AT95918579 T AT 95918579T AT 95918579 T AT95918579 T AT 95918579T AT E181326 T1 ATE181326 T1 AT E181326T1
Authority
AT
Austria
Prior art keywords
nucleoside analogue
diastereoselective
production
diastereoselective production
nucleoside
Prior art date
Application number
AT95918579T
Other languages
English (en)
Inventor
Michael David Goodyear
P Owen Dwyer
Malcolm Leithead Hill
Andrew Jonathan Whitehead
Roy Hornby
Peter Hallett
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE181326(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9408103A external-priority patent/GB9408103D0/en
Priority claimed from GB9408091A external-priority patent/GB9408091D0/en
Priority claimed from GB9408112A external-priority patent/GB9408112D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE181326T1 publication Critical patent/ATE181326T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT95918579T 1994-04-23 1995-04-21 Verfahren zu diastereoselektiven herstellung von nucleosid analoga ATE181326T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9408103A GB9408103D0 (en) 1994-04-23 1994-04-23 Chemical compounds
GB9408091A GB9408091D0 (en) 1994-04-23 1994-04-23 Process
GB9408112A GB9408112D0 (en) 1994-04-23 1994-04-23 Process

Publications (1)

Publication Number Publication Date
ATE181326T1 true ATE181326T1 (de) 1999-07-15

Family

ID=27267157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95918579T ATE181326T1 (de) 1994-04-23 1995-04-21 Verfahren zu diastereoselektiven herstellung von nucleosid analoga

Country Status (30)

Country Link
US (2) US6051709A (de)
EP (1) EP0757684B1 (de)
JP (2) JP4056558B2 (de)
KR (1) KR100241842B1 (de)
CN (2) CN1151146C (de)
AP (1) AP704A (de)
AT (1) ATE181326T1 (de)
AU (1) AU696612B2 (de)
BG (1) BG62810B1 (de)
BR (1) BR9507499A (de)
CZ (1) CZ293827B6 (de)
DE (1) DE69510347T2 (de)
DK (1) DK0757684T3 (de)
EE (1) EE03442B1 (de)
ES (1) ES2133769T3 (de)
FI (1) FI120401B (de)
GR (1) GR3031043T3 (de)
HK (1) HK1004221A1 (de)
HU (1) HU218044B (de)
IL (1) IL113432A (de)
IS (1) IS1844B (de)
NO (2) NO307179B1 (de)
NZ (1) NZ285396A (de)
PL (1) PL180090B1 (de)
RO (2) RO117916B1 (de)
RU (1) RU2158736C2 (de)
SK (1) SK281327B6 (de)
TW (1) TW487704B (de)
UA (1) UA43362C2 (de)
WO (1) WO1995029174A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
EP0869953A1 (de) * 1994-10-22 1998-10-14 Chong Kun Dang Corp Nucleosid-derivate und verfahren zu ihrer herstellung
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
RU2439069C2 (ru) * 1998-08-12 2012-01-10 Гайлид Сайенсиз, Инк. Способ получения 1,3-оксатиолановых нуклеозидов
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
CA2690137C (en) * 2001-03-01 2012-11-13 Gilead Sciences, Inc. Polymorphic and other crystalline forms of cis-ftc
US6600044B2 (en) 2001-06-18 2003-07-29 Brantford Chemicals Inc. Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
WO2003027106A1 (en) * 2001-09-25 2003-04-03 Cadila Healthcar Limited Process for the preparation of crystalline polymorph ii of lamivudine
ITMI20030578A1 (it) * 2003-03-24 2004-09-25 Clariant Lsm Italia Spa Processo ed intermedi per la preparazione di emtricitabina
US20050187913A1 (en) 2003-05-06 2005-08-25 Yoram Nelken Web-based customer service interface
CN101307048B (zh) * 2007-05-18 2011-03-23 上海迪赛诺医药发展有限公司 立体选择性制备拉米夫定的方法
US20100190982A1 (en) * 2007-09-17 2010-07-29 Janardhana Rao Vascuri Process for the preparation of lamivudine form i
EP2048151A1 (de) * 2007-10-10 2009-04-15 Cilag AG Verfahren zur Herstellung von Nukleosiden durch direkte Glykosidation der Nukleosidbase
WO2009069013A1 (en) * 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Crystalline form i of lamivudine and its preparation
AU2008331167A1 (en) * 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine
WO2009069011A1 (en) 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Process for the preparation of substituted 1,3-oxathiolanes
WO2009084033A2 (en) * 2007-12-07 2009-07-09 Matrix Laboratories Limited Process for producing 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yi]cytosine
CN101391997B (zh) * 2008-09-18 2010-12-22 江苏科本医药化学有限公司 一种恩曲他滨中间体的合成方法
CN101362752B (zh) * 2008-09-18 2011-12-28 浙江教育学院 一种拉米夫定中间体的合成方法
WO2010082128A1 (en) 2009-01-19 2010-07-22 Aurobindo Pharma Limited Process for the preparation of cis-nucleoside derivative
KR101474570B1 (ko) 2009-04-13 2014-12-19 주식회사 대희화학 라미부딘의 신규한 중간체 및 이의 제조방법
CN101544632B (zh) * 2009-04-24 2011-09-07 湖南千金湘江药业股份有限公司 拉米夫定非对映选择合成方法
WO2011045815A2 (en) 2009-10-14 2011-04-21 Matrix Laboratories Ltd. Process for the preparation of lamivudine and novel salts in the manufacture thereof
KR20170078868A (ko) 2010-01-27 2017-07-07 비이브 헬쓰케어 컴퍼니 항바이러스 치료
US20120295930A1 (en) 2010-02-03 2012-11-22 Shankar Rama Novel process for the preparation of cis-nucleoside derivative
CN102167696B (zh) 2010-02-25 2013-09-18 南京正大天晴制药有限公司 拉米夫定草酸盐及其制备方法
EP2542551B1 (de) 2010-03-04 2014-08-27 Ranbaxy Laboratories Limited Verfahren zur stereoselektiven synthese von 5-fluor-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosin
CN101830893A (zh) * 2010-05-31 2010-09-15 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备工艺
CN102399213A (zh) * 2010-09-08 2012-04-04 重庆医药工业研究院有限责任公司 拉米夫定单邻苯二甲酸盐及其合成方法
WO2012062835A1 (en) 2010-11-12 2012-05-18 Glaxo Wellcome Manufacturing Pte Ltd Novel pharmaceutical compositions
ES2729824T3 (es) 2011-04-08 2019-11-06 Laurus Labs Ltd Formas sólidas de compuestos antirretrovirales, procedimiento para la preparación y composición farmacéutica de los mismos
CN102796088B (zh) * 2012-05-21 2015-06-10 湖南千金湘江药业股份有限公司 一种拉米夫定的制备方法
CN103450166A (zh) * 2012-05-31 2013-12-18 上海迪赛诺药业有限公司 制备核苷化合物的方法
CN103864835A (zh) * 2013-03-26 2014-06-18 安徽贝克联合制药有限公司 一种提高拉米夫定中间体立体选择性制备方法
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
CN103694231A (zh) * 2013-11-28 2014-04-02 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备方法
US9571109B2 (en) * 2015-03-27 2017-02-14 International Business Machines Corporation Voltage controlled oscillator runaway prevention
CN106146481A (zh) * 2015-04-07 2016-11-23 江苏普信制药有限公司 一种核苷类似物的制备方法
CN105037340B (zh) * 2015-07-14 2018-08-10 福建广生堂药业股份有限公司 一种拉米夫定关键中间体手性异构体杂质的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6175008B1 (en) * 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
PT674634E (pt) * 1989-02-08 2003-09-30 Iaf Biochem Int Processos para preparar 1,3-oxatiolanos substituidos com propriedades antivirais
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
DK0513917T4 (da) 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues

Also Published As

Publication number Publication date
RU2158736C2 (ru) 2000-11-10
RO118714B1 (ro) 2003-09-30
BG100916A (en) 1997-07-31
SK281327B6 (sk) 2001-02-12
CN1149871A (zh) 1997-05-14
FI964251A0 (fi) 1996-10-22
HU9602925D0 (en) 1996-12-30
JPH10502615A (ja) 1998-03-10
UA43362C2 (uk) 2001-12-17
AP9600871A0 (en) 1996-10-31
ES2133769T3 (es) 1999-09-16
EP0757684B1 (de) 1999-06-16
IL113432A (en) 2000-11-21
TW487704B (en) 2002-05-21
HU218044B (hu) 2000-05-28
US6051709A (en) 2000-04-18
BR9507499A (pt) 1997-09-23
IS4366A (is) 1996-09-27
CN1290841C (zh) 2006-12-20
NO964487L (no) 1996-12-17
JP4056558B2 (ja) 2008-03-05
FI964251A (fi) 1996-10-22
CN1151146C (zh) 2004-05-26
HK1004221A1 (en) 1998-11-20
WO1995029174A1 (en) 1995-11-02
US6329522B1 (en) 2001-12-11
PL316904A1 (en) 1997-02-17
NO313096B1 (no) 2002-08-12
CZ293827B6 (cs) 2004-08-18
IS1844B (is) 2003-01-30
NZ285396A (en) 1998-10-28
KR100241842B1 (ko) 2000-03-02
IL113432A0 (en) 1995-07-31
PL180090B1 (pl) 2000-12-29
AP704A (en) 1998-12-04
NO307179B1 (no) 2000-02-21
EE9600134A (et) 1997-04-15
FI120401B (fi) 2009-10-15
BG62810B1 (bg) 2000-08-31
DE69510347D1 (de) 1999-07-22
DE69510347T2 (de) 1999-11-18
GR3031043T3 (en) 1999-12-31
NO995646L (no) 1999-11-17
RO117916B1 (ro) 2002-09-30
CN1500782A (zh) 2004-06-02
CZ309696A3 (en) 1997-04-16
NO995646D0 (no) 1999-11-17
NO964487D0 (no) 1996-10-22
EP0757684A1 (de) 1997-02-12
DK0757684T3 (da) 2000-01-17
SK135596A3 (en) 1997-07-09
EE03442B1 (et) 2001-06-15
AU696612B2 (en) 1998-09-17
JP2007217425A (ja) 2007-08-30
AU2447195A (en) 1995-11-16
HUT76296A (en) 1997-07-28

Similar Documents

Publication Publication Date Title
ATE181326T1 (de) Verfahren zu diastereoselektiven herstellung von nucleosid analoga
DE69310749D1 (de) Verfahren zur herstellung von vitaminangereichtem getreide
DE69525373D1 (de) Verfahren zur herstellung von alumosilikatderivaten
DE19680669T1 (de) Verfahren zum Verringern der Viskosität von Schokolade
DE59609854D1 (de) Verfahren zur herstellung von verkappten polyarylenethern
DE59608641D1 (de) Verfahren zur Herstellung von Nikotinsäureamid
DE69619067D1 (de) Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten
DE59603916D1 (de) Verfahren zur Herstellung von Imidazo-Benzodiazepin-Derivaten
DE69625253D1 (de) Verfahren zur Herstellung von Imidazochinazolinon-Derivaten
DE59707046D1 (de) Kontinuierliches Verfahren zur Herstellung von 4-Aminopiperidinen
DE69825179D1 (de) Neues verfahren zur herstellung von cyklosporinderivaten
DE69417527D1 (de) Verfahren zu Herstellung von alfa-Tocoferol Derivaten
ATA210093A (de) Verfahren zur herstellung von cellulosecarbamat
DE69522745D1 (de) Verfahren zum Abbau von Polysiloxanen
DE69635421T2 (de) Verfahren zur herstellung von 2-chlorthiazolderivaten
DE69111327D1 (de) Block von Mikroverbindungsstiften und Verfahren zu dessen Herstellung.
DE69403571D1 (de) Verfahren zur Herstellung von Acrylamid
DE59601895D1 (de) Verfahren zur herstellung von butyrolactonen
DE69604875D1 (de) Verfahren zur Herstellung von Cyclopentadienylderivaten
DE69324118D1 (de) Verfahren zur Herstellung von Riboflavin
DE69610837D1 (de) Verfahren zur herstellung von laubholzelementen
DE59402263D1 (de) Verfahren zur Herstellung von N-substituierten Pyrrolid-2-onen
DE69711326D1 (de) Verfahren zur Herstellung von Ethylaminen
DE69405922D1 (de) Verfahren zur Herstellung von 4-substituierten Azetidinon-Derivaten
DE69431537D1 (de) Verfahren zur Herstellung von 5-Trifluormethyluracil-Derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification